A nonsynonymous functional variant in integrin-αM (encoded by ITGAM) is associated with systemic lupus erythematosus
- 20 January 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Genetics
- Vol. 40 (2), 152-154
- https://doi.org/10.1038/ng.71
Abstract
We identified and replicated an association between ITGAM (CD11b) at 16p11.2 and risk of systemic lupus erythematosus (SLE) in 3,818 individuals of European descent. The strongest association was at a nonsynonymous SNP, rs1143679 (P = 1.7 x 10(-17), odds ratio = 1.78). We further replicated this association in two independent samples of individuals of African descent (P = 0.0002 and 0.003; overall meta-analysis P = 6.9 x 10(-22)). The genetic association between ITGAM and SLE implicates the alpha(M)beta2-integrin adhesion pathway in disease development.Keywords
This publication has 11 references indexed in Scilit:
- α-Chain phosphorylation of the human leukocyte CD11b/CD18 (Mac-1) integrin is pivotal for integrin activation to bind ICAMs and leukocyte extravasationBlood, 2006
- Both Fcγ and complement receptors mediate transfer of immune complexes from erythrocytes to human macrophages under physiological flow conditionsin vitroClinical and Experimental Immunology, 2006
- Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysisHuman Genetics, 2005
- The Fourth Blade within the β-Propeller Is Involved Specifically in C3bi Recognition by Integrin αMβ2Journal of Biological Chemistry, 2003
- Engineered allosteric mutants of the integrin alphaMbeta2 I domain: structural and functional studiesBiochemical Journal, 2003
- Association Mapping in Structured PopulationsAmerican Journal of Human Genetics, 2000
- The Future of Genetic Studies of Complex Human DiseasesScience, 1996
- Defect of a complement receptor 3 epitope in a patient with systemic lupus erythematosus.JCI Insight, 1993
- Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mappingNature, 1989
- Surface expression of gp165/95, the complement receptor CR3, as a marker of disease activity in systemic lupus erythematosusClinical Immunology and Immunopathology, 1988